DC Field | Value | Language |
dc.contributor.author | Buruiană, Sanda | |
dc.contributor.author | Corcimaru, Ion | |
dc.contributor.author | Robu, Maria | |
dc.contributor.author | Musteaţă, Larisa | |
dc.contributor.author | Gladâş, Valentina | |
dc.contributor.author | Chiu, Maria | |
dc.contributor.author | Popescu, Maria | |
dc.contributor.author | Munteanu, Victor | |
dc.date.accessioned | 2019-06-22T12:43:26Z | - |
dc.date.available | 2019-06-22T12:43:26Z | - |
dc.date.issued | 2010 | |
dc.identifier.citation | BURUIANĂ, Sanda, CORCIMARU, Ion et al. Aspecte clinice ale limfoamelor non-Hodgkin indolente. In: Anale Ştiințifice ale USMF “Nicolae Testemiţanu”. Ed. a 11-a. Chișinău: CEP Medicina, 2010, vol. 3: Probleme actuale in medicina interna, pp. 335-339 | en_US |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/1794 | - |
dc.description | Catedra Hematologie şi Oncologie USMF “N.Testemiţanu” | en_US |
dc.description.abstract | The clinical features of indolent non-Hodgkin’s lymphomas (NHL) have been studied in 167 patients aged 20 to 80. It has been noticed that the indolent non-Hodgkin’s lymphomas rarely develop in young people, and the frequency increases with age, reaching the top in patients over 60. The onset of indolent NHL predominated in spleen (35.9%), peripheral lymph nodes (31.1%), Waldeyer’s lymphoid ring (19.2%). Most rarely the indolent NHL primarily developed in the gastrointestinal tract (9.0%), abdominal lymph nodes (3.6%), mediastinal lymph nodes (1.2%). The bone marrow was involved most often during the disease dissemination (84.0%). The overall 5-year survival in patients with indolent non-Hodgkin’s lymphomas was 55.3%.
Au fost studiate manifestările clinice la 167 pacienţi cu limfoame non-Hodgkin (NHL) indolente în vârsta de la 20 până la 80 de ani. S-a observat că LNH indolente rar se dezvoltă la persoanele tinere. Frecvenţa lor creşte odată cu vârsta, atingând maximum la pacienţi în vârsta de peste 60 de ani. Debutul LNH indolente a avut loc mai frecvent în splină (35,9%), ganglionii limfatici periferici (31,1%), inelul limfatic Waldeyer (19,2%). Rar s-a dezvoltat LNH indolente primar în tractul gastrointestinal (9,0%), ganglionii limfatici abdominali (3,6%) şi mediastinali (1,2%). La etapa de generalizare a LNH frecvent a fost afectată măduva oaselor (84,0%). Supravieţuirea pacienţilor cu LNH indolente peste 5 ani a fost egală cu 55,3%. | en_US |
dc.language.iso | ro | en_US |
dc.publisher | CEP Medicina | en_US |
dc.title | Aspecte clinice ale limfoamelor non-Hodgkin indolente | en_US |
dc.title.alternative | Clinical features of indolent non-Hodgkin’s lymphomas | en_US |
dc.type | Article | en_US |
Appears in Collections: | Hematologie, oncologie
|